Gilead Sciences is building out its pipeline through a multi-billion dollar deal to acquire Tubulis, a startup with two targeted therapies in clinical testing. While those therapies are in development for cancer, Tubulis also brings the platform technologies that produced them, which Gilead could apply to indications beyond oncology. In addition to a $3.15 billion […]
Gilead’s Pipeline Strategy Takes Shape With $3B Acquisition of Cancer Biotech Tubulis
Hot this week
Business
Auto-component maker Sundram Fasteners’ Q3 net profits at Rs 116.19 cr
Auto-component maker Sundram Fasteners Ltd has reported a...
Global News
Quick Facts About Mexico’s Jewish President-elect, Claudia Sheinbaum
Mexico elected a new president this week, with...
Israel News
How Does The Dichotomy Of Secularism And Religion Manifest In Israeli Politics?
Over the years, the interplay between secularism and religion...
Business
Agritech in Israel – Innovations Transforming Global Agriculture
With a wealth of innovative technologies, Israel has emerged...
Israel News
Mamdani calls for a permanent end to NYC investments in Israel Bonds
New York City Mayoral Candidate Zohran Mamdanni on...
Topics
Related Articles
Popular Categories
Previous article![Make What Great?! Marjorie Taylor Greene & Candace Owens Blast President Trump’s Easter Threat To Iran Ahead Of Ceasefire Rejection]( "Make What Great?! Marjorie Taylor Greene & Candace Owens Blast President Trump’s Easter Threat To Iran Ahead Of Ceasefire Rejection")
Next article![Arsenal result has just handed Liverpool and Chelsea a massive UCL boost]( "Arsenal result has just handed Liverpool and Chelsea a massive UCL boost")
